Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 4 Dec 2003 |
| Genmab, and ACE BioSciences to Develop Product to Treat Fungal Infections | 17 Nov 2003 |
| Genmab, financial calendar 2004 | 14 Nov 2003 |
| Genmab, Passing of Extraordinary General Meeting in Genmab A/S - Grant of Warrants | 11 Nov 2003 |
| Genmab, articles of association as per 11 November 2003 | 11 Nov 2003 |